About Pierogi Therapeutics
Pierogi Therapeutics is a private company based in Pittsburgh, Pennsylvania, incorporated in 2025 in Delaware. It has reported $50,000 raised in one offering on Form D since June 2026. Its chief executive is Samuel Koby.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 9, 2026 | Jun 17, 2026 | $50,000of $4.0M target | 1 | $50,000 | OptionsRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Pierogi Therapeutics's Form D filed Jun 17, 2026.
FG
SK
Samuel Koby
Chief Executive Officer and director